{"pmid":32239532,"title":"Our Italian Experience Using Lung Ultrasound for Identification, Grading and Serial Follow-up of Severity of Lung Involvement for Management of Patients with COVID-19.","text":["Our Italian Experience Using Lung Ultrasound for Identification, Grading and Serial Follow-up of Severity of Lung Involvement for Management of Patients with COVID-19.","Lung ultrasound (LU) has rapidly become a tool for assessment of patients stricken by the novel coronavirus 2019 (COVID-19). Over the past two and a half months (January, February and first half of March 2020) we have used this modality for identification of lung involvement along with pulmonary severity in patients with suspected or documented COVID-19 infection. Use of LU has helped us in clinical decision making and reduced the use of both chest x-rays and computed tomography (CT).","Echocardiography","Vetrugno, Luigi","Bove, Tiziana","Orso, Daniele","Barbariol, Federico","Bassi, Flavio","Boero, Enrico","Ferrari, Giovanni","Kong, Robert","Lichtenstein, Daniel A","32239532"],"abstract":["Lung ultrasound (LU) has rapidly become a tool for assessment of patients stricken by the novel coronavirus 2019 (COVID-19). Over the past two and a half months (January, February and first half of March 2020) we have used this modality for identification of lung involvement along with pulmonary severity in patients with suspected or documented COVID-19 infection. Use of LU has helped us in clinical decision making and reduced the use of both chest x-rays and computed tomography (CT)."],"journal":"Echocardiography","authors":["Vetrugno, Luigi","Bove, Tiziana","Orso, Daniele","Barbariol, Federico","Bassi, Flavio","Boero, Enrico","Ferrari, Giovanni","Kong, Robert","Lichtenstein, Daniel A"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32239532","week":"202014|Mar 30 - Apr 05","doi":"10.1111/echo.14664","keywords":["COVID-19","Lung Ultrasound","interstitial syndrome"],"source":"PubMed","locations":["Italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Diagnosis"],"weight":1,"_version_":1662996001727709185,"score":7.6048946,"similar":[{"pmid":32227492,"title":"Proposal for international standardization of the use of lung ultrasound for COVID-19 patients; a simple, quantitative, reproducible method.","text":["Proposal for international standardization of the use of lung ultrasound for COVID-19 patients; a simple, quantitative, reproducible method.","Growing evidences are showing the usefulness of lung ultrasound in patients with COVID-19. Sars-CoV-2 has now spread in almost every country in the world. In this study, we share our experience and propose a standardized approach in order to optimize the use of lung ultrasound in covid-19 patients. We focus on equipment, procedure, classification and data-sharing. This article is protected by copyright. All rights reserved.","J Ultrasound Med","Soldati, Gino","Smargiassi, Andrea","Inchingolo, Riccardo","Buonsenso, Danilo","Perrone, Tiziano","Briganti, Domenica Federica","Perlini, Stefano","Torri, Elena","Mariani, Alberto","Mossolani, Elisa Eleonora","Tursi, Francesco","Mento, Federico","Demi, Libertario","32227492"],"abstract":["Growing evidences are showing the usefulness of lung ultrasound in patients with COVID-19. Sars-CoV-2 has now spread in almost every country in the world. In this study, we share our experience and propose a standardized approach in order to optimize the use of lung ultrasound in covid-19 patients. We focus on equipment, procedure, classification and data-sharing. This article is protected by copyright. All rights reserved."],"journal":"J Ultrasound Med","authors":["Soldati, Gino","Smargiassi, Andrea","Inchingolo, Riccardo","Buonsenso, Danilo","Perrone, Tiziano","Briganti, Domenica Federica","Perlini, Stefano","Torri, Elena","Mariani, Alberto","Mossolani, Elisa Eleonora","Tursi, Francesco","Mento, Federico","Demi, Libertario"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32227492","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jum.15285","keywords":["Covid-19","Lung Ultrasound","POCUS","Scoring system"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1662819280280879104,"score":218.63783},{"pmid":32196627,"title":"Point-of-Care Lung Ultrasound findings in novel coronavirus disease-19 pnemoniae: a case report and potential applications during COVID-19 outbreak.","text":["Point-of-Care Lung Ultrasound findings in novel coronavirus disease-19 pnemoniae: a case report and potential applications during COVID-19 outbreak.","An outbreak of a novel coronavirus disease-19 (nCoV-19) infection began in December 2019 in Wuhan, China, and now involved the whole word. Several health workers have been infected in different countries. We report the case of a young man with documented nCoV-19 infection evaluated with lung ultrasound and discuss potential applications of lung ultrasound in this setting. Lung ultrasound allowed the identification of nCoV-19 infection at bed-side. Moreover, lung ultrasound can have several other advantages, such as reduced health worker exposition to infected patients, repeatability during follow-up, low-costs and easier application in low-resource settings.","Eur Rev Med Pharmacol Sci","Buonsenso, D","Piano, A","Raffaelli, F","Bonadia, N","de Gaetano Donati, K","Franceschi, F","32196627"],"abstract":["An outbreak of a novel coronavirus disease-19 (nCoV-19) infection began in December 2019 in Wuhan, China, and now involved the whole word. Several health workers have been infected in different countries. We report the case of a young man with documented nCoV-19 infection evaluated with lung ultrasound and discuss potential applications of lung ultrasound in this setting. Lung ultrasound allowed the identification of nCoV-19 infection at bed-side. Moreover, lung ultrasound can have several other advantages, such as reduced health worker exposition to infected patients, repeatability during follow-up, low-costs and easier application in low-resource settings."],"journal":"Eur Rev Med Pharmacol Sci","authors":["Buonsenso, D","Piano, A","Raffaelli, F","Bonadia, N","de Gaetano Donati, K","Franceschi, F"],"date":"2020-03-21T11:00:00Z","year":2020,"_id":"32196627","week":"202012|Mar 16 - Mar 22","doi":"10.26355/eurrev_202003_20549","source":"PubMed","locations":["China","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1662334543102738432,"score":185.54573},{"pmid":32207208,"title":"How to perform lung ultrasound in pregnant women with suspected COVID-19 infection.","text":["How to perform lung ultrasound in pregnant women with suspected COVID-19 infection.","Under specific circumstances, such as during the current COVID-19 outbreak, pregnant women can be a target for respiratory infection, and lung examination may be required as part of their clinical evaluation, ideally avoiding exposure to radiation. We propose a practical approach for obstetricians/gynecologists to perform lung ultrasound, showing potential applications, semiology and practical aspects, which should be of particular importance in emergency situations, such as the current pandemic infection of COVID-19. This article is protected by copyright. All rights reserved.","Ultrasound Obstet Gynecol","Moro, F","Buonsenso, D","Moruzzi, M C","Inchingolo, R","Smargiassi, A","Demi, L","Larici, A R","Scambia, G","Lanzone, A","Testa, A C","32207208"],"abstract":["Under specific circumstances, such as during the current COVID-19 outbreak, pregnant women can be a target for respiratory infection, and lung examination may be required as part of their clinical evaluation, ideally avoiding exposure to radiation. We propose a practical approach for obstetricians/gynecologists to perform lung ultrasound, showing potential applications, semiology and practical aspects, which should be of particular importance in emergency situations, such as the current pandemic infection of COVID-19. This article is protected by copyright. All rights reserved."],"journal":"Ultrasound Obstet Gynecol","authors":["Moro, F","Buonsenso, D","Moruzzi, M C","Inchingolo, R","Smargiassi, A","Demi, L","Larici, A R","Scambia, G","Lanzone, A","Testa, A C"],"date":"2020-03-25T11:00:00Z","year":2020,"_id":"32207208","week":"202013|Mar 23 - Mar 29","doi":"10.1002/uog.22028","keywords":["COVID-19","lung ultrasound","pregnancy"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1662334543414165504,"score":144.77072},{"pmid":32208840,"title":"Clinical observation and management of COVID-19 patients.","text":["Clinical observation and management of COVID-19 patients.","Three leading infectious disease experts in China were invited to share their bedside observations in the management of COVID-19 patients. Professor Taisheng Li was sent to Wuhan to provide frontline medical care. He depicts the clinical course of SARS-CoV-2 infection. Furthermore, he observes the significant abnormality of coagulation function and proposes that the early intravenous immunoglobulin and low molecular weight heparin anticoagulation therapy are very important. Professor Hongzhou Lu, a leader in China to try various anti-viral drugs, expresses concern on the quality of the ongoing clinical trials as most trials are small in scale and repetitive in nature, and emphasizes the importance of the quick publication of clinical trial results. Regarding the traditional Chinese medicine, Professor Lu suggests to develop a creative evaluation system because of the complicated chemical compositions. Professor Wenhong Zhang is responsible for Shanghai's overall clinical management of the COVID-19 cases. He introduces the team approach to manage COVID-19 patients. For severe or critically ill patients, in addition to the respiratory supportive treatment, timely multiorgan evaluation and treatment is very crucial. The medical decisions and interventions are carefully tailored to the unique characteristics of each patient.","Emerg Microbes Infect","Li, Taisheng","Lu, Hongzhou","Zhang, Wenhong","32208840"],"abstract":["Three leading infectious disease experts in China were invited to share their bedside observations in the management of COVID-19 patients. Professor Taisheng Li was sent to Wuhan to provide frontline medical care. He depicts the clinical course of SARS-CoV-2 infection. Furthermore, he observes the significant abnormality of coagulation function and proposes that the early intravenous immunoglobulin and low molecular weight heparin anticoagulation therapy are very important. Professor Hongzhou Lu, a leader in China to try various anti-viral drugs, expresses concern on the quality of the ongoing clinical trials as most trials are small in scale and repetitive in nature, and emphasizes the importance of the quick publication of clinical trial results. Regarding the traditional Chinese medicine, Professor Lu suggests to develop a creative evaluation system because of the complicated chemical compositions. Professor Wenhong Zhang is responsible for Shanghai's overall clinical management of the COVID-19 cases. He introduces the team approach to manage COVID-19 patients. For severe or critically ill patients, in addition to the respiratory supportive treatment, timely multiorgan evaluation and treatment is very crucial. The medical decisions and interventions are carefully tailored to the unique characteristics of each patient."],"journal":"Emerg Microbes Infect","authors":["Li, Taisheng","Lu, Hongzhou","Zhang, Wenhong"],"date":"2020-03-27T11:00:00Z","year":2020,"_id":"32208840","week":"202013|Mar 23 - Mar 29","doi":"10.1080/22221751.2020.1741327","keywords":["Clinical management","SARS","SARS-CoV-2","antiviral drugs","coronavirus"],"source":"PubMed","locations":["Chinese","Shanghai","China","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1662444220160409600,"score":133.9063},{"pmid":32053470,"title":"Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia.","text":["Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia.","Background Chest CT is used to assess the severity of lung involvement in COVID-19 pneumonia. Purpose To determine the change in chest CT findings associated with COVID-19 pneumonia from initial diagnosis until patient recovery. Materials and Methods This retrospective review included patients with RT-PCR confirmed COVID-19 infection presenting between 12 January 2020 to 6 February 2020. Patients with severe respiratory distress and/ or oxygen requirement at any time during the disease course were excluded. Repeat Chest CT was obtained at approximately 4 day intervals. The total CT score was the sum of lung involvement (5 lobes, score 1-5 for each lobe, range, 0 none, 25 maximum) was determined. Results Twenty one patients (6 males and 15 females, age 25-63 years) with confirmed COVID-19 pneumonia were evaluated. These patients under went a total of 82 pulmonary CT scans with a mean interval of 4+/-1 days (range: 1-8 days). All patients were discharged after a mean hospitalized period of 17+/-4 days (range: 11-26 days). Maximum lung involved peaked at approximately 10 days (with the calculated total CT score of 6) from the onset of initial symptoms (R2=0.25), p<0.001). Based on quartiles of patients from day 0 to day 26 involvement, 4 stages of lung CT were defined: Stage 1 (0-4 days): ground glass opacities (GGO) in 18/24 (75%) patients with the total CT score of 2+/-2; (2)Stage-2 (5-8d days): increased crazy-paving pattern 9/17 patients (53%) with a increase in total CT score (6+/-4, p=0.002); (3) Stage-3 (9-13days): consolidation 19/21 (91%) patients with the peak of total CT score (7+/-4); (4) Stage-4 (>/=14 days): gradual resolution of consolidation 15/20 (75%) patients with a decreased total CT score (6+/-4) without crazy-paving pattern. Conclusion In patients recovering from COVID-19 pneumonia (without severe respiratory distress during the disease course), lung abnormalities on chest CT showed greatest severity approximately 10 days after initial onset of symptoms.","Radiology","Pan, Feng","Ye, Tianhe","Sun, Peng","Gui, Shan","Liang, Bo","Li, Lingli","Zheng, Dandan","Wang, Jiazheng","Hesketh, Richard L","Yang, Lian","Zheng, Chuansheng","32053470"],"abstract":["Background Chest CT is used to assess the severity of lung involvement in COVID-19 pneumonia. Purpose To determine the change in chest CT findings associated with COVID-19 pneumonia from initial diagnosis until patient recovery. Materials and Methods This retrospective review included patients with RT-PCR confirmed COVID-19 infection presenting between 12 January 2020 to 6 February 2020. Patients with severe respiratory distress and/ or oxygen requirement at any time during the disease course were excluded. Repeat Chest CT was obtained at approximately 4 day intervals. The total CT score was the sum of lung involvement (5 lobes, score 1-5 for each lobe, range, 0 none, 25 maximum) was determined. Results Twenty one patients (6 males and 15 females, age 25-63 years) with confirmed COVID-19 pneumonia were evaluated. These patients under went a total of 82 pulmonary CT scans with a mean interval of 4+/-1 days (range: 1-8 days). All patients were discharged after a mean hospitalized period of 17+/-4 days (range: 11-26 days). Maximum lung involved peaked at approximately 10 days (with the calculated total CT score of 6) from the onset of initial symptoms (R2=0.25), p<0.001). Based on quartiles of patients from day 0 to day 26 involvement, 4 stages of lung CT were defined: Stage 1 (0-4 days): ground glass opacities (GGO) in 18/24 (75%) patients with the total CT score of 2+/-2; (2)Stage-2 (5-8d days): increased crazy-paving pattern 9/17 patients (53%) with a increase in total CT score (6+/-4, p=0.002); (3) Stage-3 (9-13days): consolidation 19/21 (91%) patients with the peak of total CT score (7+/-4); (4) Stage-4 (>/=14 days): gradual resolution of consolidation 15/20 (75%) patients with a decreased total CT score (6+/-4) without crazy-paving pattern. Conclusion In patients recovering from COVID-19 pneumonia (without severe respiratory distress during the disease course), lung abnormalities on chest CT showed greatest severity approximately 10 days after initial onset of symptoms."],"journal":"Radiology","authors":["Pan, Feng","Ye, Tianhe","Sun, Peng","Gui, Shan","Liang, Bo","Li, Lingli","Zheng, Dandan","Wang, Jiazheng","Hesketh, Richard L","Yang, Lian","Zheng, Chuansheng"],"date":"2020-02-14T11:00:00Z","year":2020,"_id":"32053470","week":"20207|Feb 10 - Feb 16","doi":"10.1148/radiol.2020200370","source":"PubMed","locations":["Pneumonia"],"topics":["Diagnosis"],"weight":1,"_version_":1663095626222534656,"score":129.41685}]}